Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUltrasis Plc Regulatory News (ULT)

  • There is currently no data for ULT

Re Contract

22 Sep 2008 08:28

RNS Number : 9397D
Ultrasis PLC
22 September 2008
 



Date: 22nd September 2008

Ultrasis plc announces a £247,000 contract with Ashton, Leigh and Wigan PCT to provide "Beating the Blues" for the treatment of depression.

The North West is leading the way in providing "Beating the Blues" the only computerised cognitive behavioural therapy (CCBT) program approved by The National Institute for Health and Clinical Excellence ("NICE") for the treatment of depression. Ashton, Leigh and Wigan Primary Care Trust ("PCT") has followed Oldham PCT which made the same commitment for its patients in February.

Under a three year agreement, which has a value of £247,000 over three years, Ashton, Leigh and Wigan PCT has commissioned the full level of treatments recommended by NICE for its patient population of 330,000.

Ashton, Leigh and Wigan PCT has also renewed its commitment to the Relief suite of self help eTherapy programs provided by Ultrasis. These online programs for anxiety, depression, stress and insomnia have been used successfully over the last 4 years with the PCT's population.

Nigel Brabbins, Ultrasis' Chief Executive, said: "This contract once again demonstrates the confidence that commissioners have in Beating the Blues for the treatment of mild and moderate depression. We are delighted that the Ashton, Leigh and Wigan PCT has made this commitment and we look forward to helping them deliver significantly improved access to psychological therapies for their patients."

-ends-

For further information please contact:

Nigel Brabbins Ultrasis E-Mail: ultrasis@ultrasis.com Telephone: +44 (0) 20 7566 3900 Fax: +44 (0) 20 7253 5313

Geoff Nash FinnCap Nominated Adviser and Joint BrokerTelephone: +44 (0) 20 7600 1658

John Webb Marshall Securities Joint Broker Telephone: +44 (0) 207 490 3788

Karen White/Sarah Rice

JBP Public Relations

E-Mail: karen@jbp.co.uksarah@jbp.co.uk

Telephone: +44 (0) 117 9073400/ +44 (0) 7787 148393

Editors Notes:

Ultrasis plc is a healthcare company with core expertise in health, psychology, software development and programme management. The Company delivers computerised healthcare products to the NHS, the corporate sector and other healthcare providers in the UK and internationally. 

Ultrasis was the first company to offer computerised products based on Cognitive Behavioural Therapy (CBT) and interactive multimedia, and is the world leader in this field. The products help people tackle stress, anxiety and depression, and a full spectrum of related chronic conditions. 

Beating the Blues is an eight-week, web-based treatment programme for mild and moderate depression based on Cognitive Behavioural Therapy. Following a rigorous examination by the National Institute for Health and Clinical Excellence (NICE), "Beating the Blues" was approved by NICE in February 2006 for use in the National Health Service. 

On 28 March 2007 the Secretary of State for Health announced a framework agreement for the use of cCBT in the NHS and approved "Beating the Blues", saying: "Computer-based therapy for milder, but more common mental health conditions such as depression and anxiety should be made available to any patients in England who could benefit from it from April 2007."

www.ultrasis.com 

www.thewellnessshop.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTSEMSWESASEEU
Date   Source Headline
1st Oct 20137:00 amRNSNew Customer Win
16th Sep 20139:30 amRNSBeating the Blues Research at The White House
13th Sep 20137:00 amRNSBoard Changes
9th Sep 20139:04 amRNSAcquisition & Issue of Equity
6th Sep 20137:00 amRNSDirectorate Change
2nd Sep 20132:50 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSNew corporate website
20th Aug 20137:00 amRNSContract Win
2nd Aug 201311:45 amRNSFurther US Success for Beating the Blues
1st Aug 20135:03 pmRNSIssue of Equity and Directors' Dealings
1st Aug 20137:00 amRNSNew partnership to address NHS market
5th Jul 20131:00 pmRNSIssue of Equity
17th Jun 20137:52 amRNSUltrasis US Joint Venture Success
14th Jun 20137:00 amRNSHolding(s) in Company
7th Jun 20137:00 amRNSDirectorate Change
21st May 20137:00 amRNSStrategic partnership with US Joint Venture
1st May 20133:40 pmRNSIssue of Equity and Block listing update
2nd Apr 201312:00 pmRNSChange of Adviser
20th Mar 20137:00 amRNSInterim Results
14th Feb 20137:00 amRNSCompletion of fundraising and total voting rights
4th Feb 20132:32 pmRNSIssue of Shares under Share Incentive Plan
30th Jan 20133:45 pmRNSResult of AGM
29th Jan 20137:00 amRNSProposed Financing Arrangements & Director Change
7th Jan 20137:00 amRNSAnnual Report & Notice of AGM
16th Nov 20127:00 amRNSFinal Results
5th Nov 20127:00 amRNSFurther Research Success
5th Nov 20127:00 amRNSIssue of Shares & Blocklisting Update
1st Nov 20122:15 pmRNSHolding(s) in Company
1st Nov 20127:00 amRNSNew Contract Win
2nd Aug 20128:10 amRNSCost Control and Share Incentive Plan
31st Jul 20127:00 amRNSNew customer for US Joint Venture
11th Jul 20127:00 amRNSChina Hospital Partnership
12th Jun 20122:28 pmRNSHolding(s) in Company
2nd May 20127:00 amRNSIssue of Shares & Block Listing Update
30th Apr 201211:00 amRNSGrant for BtB US Trials
24th Apr 20129:40 amRNSHolding(s) in Company
4th Apr 20127:00 amRNSInterim Results
7th Feb 201212:45 pmRNSHolding(s) in Company
1st Feb 201212:51 pmRNSIssue of Shares under Share Incentive Plan
27th Jan 20127:00 amRNSResult of AGM
26th Jan 20127:00 amRNSFirst customer for US version of Beating the Blues
25th Jan 20127:00 amRNSHolding(s) in Company
16th Jan 20127:00 amRNSCommencement of Pilot Project
9th Jan 20121:00 pmRNSCanadian Pilot
20th Dec 201111:00 amRNSAnnual Report and Notice of Annual General Meeting
8th Nov 20117:01 amRNSBlocklisting Six Monthly Update
8th Nov 20117:00 amRNSFinal Results
25th Oct 201111:00 amRNSUltrasis launches Share Incentive Plan
10th Oct 20117:00 amRNSNew Partnership
6th Oct 201112:00 pmRNSLaunch of US version of Beating the Blues

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.